Harold H. Shlevin, Director at GALECTIN THERAPEUTICS INC (GALT), sold 207,580 shares at $5.96 ($1.3M) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($1.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.95 | 35,000 | $208K | 16.6% |
| 2 | $5.95 | 25,000 | $149K | 11.9% |
| 3 | $5.96 | 20,000 | $119K | 9.5% |
| 4 | $6.00 | 20,000 | $120K | 9.6% |
| 5 | $6.01 | 4,000 | $24K | 1.9% |
| 6 | $6.02 | 35,000 |
| $211K |
| 16.8% |
| 7 | $6.02 | 35,000 | $211K | 16.8% |
| 8 | $6.27 | 16,790 | $105K | 8.4% |
| 9 | $6.27 | 16,790 | $105K | 8.4% |
| Total | $6.03 avg | 207,580 | $1.3M | 100% |
| Filing → |
| GALT | SELL | 2025-12-16 | $354K | — | Filing → |
| GALT | BUY | 2024-12-31 | $8K | — | Filing → |
| GALT | SELL | 2018-06-14 | $565K | — | Filing → |